Medical instrument research needs to intensify innovation

On November 21st at the National Convention Center, about 20,000 orthopedic doctors from around the country participated in the conference. Hundreds of doctors from all over the world were also attracted by the event and came to observe the exchanges. As domestic policies have become more favorable for medical devices, the international reputation of coa has also increased. Domestic enterprises in China have made tremendous progress in various aspects in recent years, and people in the industry generally believe that the peak of medical device industry development is coming soon. However, the phenomenon of prosperity in China's orthopedic industry does not obscure the reality that the products of domestic companies are still at the stage of “imitation” and there is still a huge gap between product development and international brands. Medical Device Technology Innovation also faces many challenges. This phenomenon has caused widespread concern and worries among people in the industry. To this end, on November 22nd, Zhejiang Kehui Medical Devices Co., Ltd. organized a seminar with the theme of “Innovation in Medical Devices under the New Situation” to attract A large number of orthopaedic surgeons and industry innovators participated.

In recent years, the medical device industry has become an important starting point for developed countries to upgrade the biomedical industry and high-end equipment manufacturing. Data show that in 2012 the global medical device output value has exceeded 400 billion U.S. dollars, accounting for 42% of the pharmaceutical market, and the production value ratio of drug chemicals in developed countries has reached 1:1. In the same period, there were 69,975 medical device product registration certificates across the country. Medical devices account for about 14% of the overall size of the medical industry. In 2013, China's total trade volume of medical devices reached US$34.31 billion, an increase of 14.13% over the same period of last year. Imports amounted to US$14.975 billion, which represented a year-on-year increase of 20.07%. There were a total of 12,123 importing enterprises, of which domestically-funded enterprises imported US$8.92 billion, accounting for 59.66%. Exports amounted to 19.335 billion U.S. dollars, an increase of 9.92% year-on-year; a total of 19,786 export enterprises, of which exports of domestic-funded enterprises amounted to 9.712 billion U.S. dollars, accounting for 50.4%.

Dr. Jiang Feng, Chairman of China's Medical Device Industry Technology Innovation Strategic Alliance pointed out that despite the rapid progress in the development of medical devices in China, there is a huge gap in the building of sustainable technological innovation capability with an industrial strategic height, which is mainly manifested in the low innovative capacity, medium and low There are many end products, there are many imitation and improvement products, and there are almost no original products. The total investment in R&D in China's pharmaceutical industry is 1% to 2% (medical equipment is 3%), and the average level in developed countries is 15% to 18% (Medical The equipment is more than 15%. This means that we have a lot of potential to tap on innovations with proprietary intellectual property technology. Jiang Feng said that more medical frontline and industry-related personnel should be mobilized and encouraged to participate in the innovation of medical devices.

Professor Jiang Baoguo, deputy director of the Department of Medicine of Peking University, has been engaged in orthopaedic clinical and scientific research work for more than 20 years. He has witnessed the development of the domestic orthopedics industry. He stood at the perspective of medical device users and compared the differences in research and development of orthopaedic medical devices at home and abroad. Policy should be more clear about the role and status of doctors in professional inventions, and reduce unnecessary reporting procedures to accelerate the path from the clinical frontline research and development to industrialization. He sincerely hopes that domestic companies can upgrade the level of research and development as soon as possible, so that Chinese doctors have the opportunity to use more medical equipment products designed by Chinese doctors and in line with the anatomical features of the Chinese people.

The continuous improvement of the level of research and development has determined the sustainable development of the medical device industry and is also crucial to enhancing the competitiveness of enterprises. Fang Ming, chairman of Zhejiang Kehui Medical Devices Co., Ltd., emphasized that the need for coordination and integration of industrial resources in the innovation of medical devices requires both the tilt and support of the country in terms of macroeconomic policies and the need to participate in all aspects of micro-level unremitting efforts. Persist and work hard. Fang Ming told a reporter from the Science and Technology Daily that this year the State has introduced and implemented a new Regulation on the Supervision and Management of Medical Devices. Not long ago, the State Council issued a "Several Opinions on Promoting the Development of the Health Services Industry," explicitly supporting innovative drugs and medical devices. With the development and industrialization of new biomedical materials, the medical device industry is facing an opportunity for development. Kehui Medical takes “science and technology for health services” as its tenet, insists on independent research and development, and pays attention to technology accumulation. It will continue to leverage on national policies, increase scientific and technological input, and work with orthopedic clinicians to develop more self-directed knowledge. Property rights "China created" products.